1. Home
  2. CYBN vs DUOT Comparison

CYBN vs DUOT Comparison

Compare CYBN & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • DUOT
  • Stock Information
  • Founded
  • CYBN 2019
  • DUOT 1990
  • Country
  • CYBN Canada
  • DUOT United States
  • Employees
  • CYBN N/A
  • DUOT N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • CYBN Health Care
  • DUOT Technology
  • Exchange
  • CYBN Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • CYBN 147.4M
  • DUOT 169.7M
  • IPO Year
  • CYBN N/A
  • DUOT N/A
  • Fundamental
  • Price
  • CYBN $6.34
  • DUOT $10.25
  • Analyst Decision
  • CYBN Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • CYBN 3
  • DUOT 2
  • Target Price
  • CYBN $85.00
  • DUOT $12.75
  • AVG Volume (30 Days)
  • CYBN 1.0M
  • DUOT 339.0K
  • Earning Date
  • CYBN 11-17-2025
  • DUOT 11-18-2025
  • Dividend Yield
  • CYBN N/A
  • DUOT N/A
  • EPS Growth
  • CYBN N/A
  • DUOT N/A
  • EPS
  • CYBN N/A
  • DUOT N/A
  • Revenue
  • CYBN N/A
  • DUOT $15,387,935.00
  • Revenue This Year
  • CYBN N/A
  • DUOT $292.26
  • Revenue Next Year
  • CYBN N/A
  • DUOT $43.21
  • P/E Ratio
  • CYBN N/A
  • DUOT N/A
  • Revenue Growth
  • CYBN N/A
  • DUOT 172.93
  • 52 Week Low
  • CYBN $4.81
  • DUOT $3.71
  • 52 Week High
  • CYBN $13.88
  • DUOT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 48.10
  • DUOT 66.05
  • Support Level
  • CYBN $6.86
  • DUOT $9.41
  • Resistance Level
  • CYBN $8.00
  • DUOT $10.70
  • Average True Range (ATR)
  • CYBN 0.48
  • DUOT 0.65
  • MACD
  • CYBN 0.06
  • DUOT 0.11
  • Stochastic Oscillator
  • CYBN 27.48
  • DUOT 84.84

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: